PS
CORT icon

Principal Securities’s Corcept Therapeutics CORT Stock Holding History

Principal Securities’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$497K Buy
+5,720
New +$345K 0.01% 1071
2025
Q4 		– Sell
-1,354
Closed -$113K – 1764
2025
Q3 		$113K Sell
1,354
-578
-30% -$41.8K ﹤0.01% 1544
2025
Q2 		$142K Buy
1,932
+689
+55% +$50K ﹤0.01% 1384
2025
Q1 		$62.6K Hold
1,243
– – ﹤0.01% 1662
2024
Q4 		$62.6K Buy
1,243
+483
+64% +$25.3K ﹤0.01% 1661
2024
Q3 		$35.2K Buy
760
+393
+107% +$14K ﹤0.01% 1846
2024
Q2 		$11.9K Buy
367
+32
+10% +$877 ﹤0.01% 2315
2024
Q1 		$8.44K Sell
335
-21
-6% -$496 ﹤0.01% 2421
2023
Q4 		$11.6K Buy
+356
New +$9.78K ﹤0.01% 2165

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Principal Securities's CORT Position: Q2 2026 in Review

Principal Securities opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 5,720 shares worth $497K. The stake represents 0.01% of the portfolio and ranks #1071 among its holdings. This is a return to the name: Principal Securities previously reported a position in CORT as recently as Q3 2025.

Principal Securities first reported a position in CORT in Q4 2023 and has held it in 9 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Principal Securities held 5,720 shares of Corcept Therapeutics worth $497K as of Q2 2026.
  • Corcept Therapeutics was a new Principal Securities position in Q2 2026.
  • Corcept Therapeutics made up 0.01% of Principal Securities's portfolio in Q2 2026, its #1071 holding.
  • Principal Securities first reported a position in Corcept Therapeutics in Q4 2023 and has held it in 9 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.